Medical

Handheld device images eyes to save brains

Handheld device images eyes to save brains
The new device measures intracranial pressure via the eye
The new device measures intracranial pressure via the eye
View 3 Images
The new device measures intracranial pressure via the eye
1/3
The new device measures intracranial pressure via the eye
Llewellyn Padayachy tests the ultrasound device
2/3
Llewellyn Padayachy tests the ultrasound device
SINTEF researcher Reidar Brekken tests the new diagnostic tool
3/3
SINTEF researcher Reidar Brekken tests the new diagnostic tool
View gallery - 3 images

When someone has a head injury, it's vitally important to know if they're experiencing elevated intracranial pressure – it can cause damage to the brain and spinal cord if left unchecked. A newly-developed device could make the diagnosis process faster and easier than ever before.

Currently, in order to see if someone has high intracranial pressure, they have to be taken to an operating room where a hole is drilled in their skull and a probe is inserted. Not only is this traumatic, invasive and expensive, but it also doesn't deliver results until well after the accident has occurred.

Invented by South African pediatric neurosurgeon Llewellyn Padayachy, the new handheld device could be used onsite or en route by ambulance crews, and doesn't require any hole-drilling.

Instead, it's held up to the patient's eye, where it uses ultrasound to image structures within the organ. If telltale changes in those structures are detected, it means that the intracranial pressure is elevated. Although users previously had to interpret the data manually in order to reach that conclusion, an artificial intelligence system now does it for them.

Llewellyn Padayachy tests the ultrasound device
Llewellyn Padayachy tests the ultrasound device

The technology was initially tested on 16 patients in South Africa, followed by a group of 28, successfully identifying individuals with elevated pressure. Norway's SINTEF research group, which has partnered with Padayachy on development of the device, is planning a larger 200-patient trial at the Ullevål University Hospital in Oslo.

"If clinical assessments can be made at accident scenes, this will make a big difference later in the patient pathway," says SINTEF researcher Reidar Brekken. "It will help to save lives and prevent potential brain damage. It will also be less expensive to implement because there will be no need to transport patients for costly surgical interventions in operating theaters in order to perform an examination."

The device is being commercialized by Norwegian company NiSonic, and is described in a paper that was recently published in the journal Operative Neurosurgery.

Source: Gemini

View gallery - 3 images
No comments
0 comments
There are no comments. Be the first!